CSL to acquire Switzerland’s Vifor Pharma for $11.7bn
CSL has signed a definitive agreement for the acquisition of all publicly held stakes of Switzerland-based Vifor Pharma in a deal worth $11.7bn (A$16.4bn) in cash.
December 16, 2021
by Pharmaceutical-Technology
Startups join CSL, Moderna in local mRNA vaccine manufacturing push
Australian biotech startups and small businesses have joined pharmaceutical majors like CSL in pitching to the federal government for a role in making mRNA products in the country, reported The Age.
July 22, 2021
by firstwordpharma
New data boosts AstraZeneca COVID-19 vaccine in US
The trials in the US, Chile and Peru showed the vaccine was 79 per cent effective at preventing symptomatic COVID-19.
March 23, 2021
by expresspharma
Australia to initiate manufacturing of vaccine candidate for Covid-19
Australia is planning to commence the manufacturing of Covid-19 vaccine candidate, AZD1222, at biotech firm CSL’s advanced manufacturing facility in Broadmeadows, Victoria.
November 10, 2020
by pharmaceutical-technology
Australia’s star vaccine maker not immune to virus anxiety: Analysis
A promise to supply Australia's 25 million people with a coronavirus vaccine, if one becomes available, has boosted CSL's profile.
October 29, 2020
by expresspharma
Australia enters $1.2bn Covid-19 vaccine supply agreement
The Government of Australia has signed a supply and production agreement valued at A$1.7bn ($1.2bn) to potentially offer a free Covid-19 vaccine to its citizens next year.
September 17, 2020
by pharmaceutical-technology
UQ’s Covid-19 vaccine shows effectiveness in preclinical studies
The University of Queensland (UQ) in Australia has reported positive data from preclinical tests of its Covid-19 vaccine candidate conducted by Viroclinics-DDL in the Netherlands.
August 28, 2020
by pharmaceutical-technology
UQ, CEPI and CSL Partner on Development and Manufacture of COVID-19 Vax Candidate
CSL appointed manufacturer for University of Queensland's "molecular clamp" enabled COVID-19 vaccine candidate.
June 9, 2020
by contractpharma
CSL teams up with CEPI and UQ for Covid-19 vaccine
Australia-based biotechnology company CSL has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Queensland (UQ) to advance the university’s Covid-19 vaccine.
June 8, 2020
by pharmaceutical-technology
Australia’s CSL says to help fund, make vaccine candidate if it proves successful
Early pre-clinical results for the vaccine candidate have shown it produced high levels of antibodies that can neutralise the virus, CSL said.
June 8, 2020
by expresspharma
Mustang Bio, CSL Behring Enter License Agreement for Stable Producer Cell Line
Cytegrity™ is a stable producer cell line developed by St. Jude Children’s Research Hospital for the treatment of X-linked severe combined immunodeficiency.
August 28, 2019
by contractpharma
Aslan Pharmaceuticals amends license agreement with CSL
Amending their previous agreement, CSL grants ASLAN full global rights to develop, manufacture and commercialise ASLAN004
June 3, 2019
by biospectrumasia